Incidence and natural history of hepatitis e virus coinfection among HIV-infected patients

AIDS

Volumn 28, Issue 13, 2014, Pages 1931-1937

  Pineda, Juan A ^a   Cifuentes, Celia ^a   Parr, Manuel ^c   Merchante, Nicolás ^a   Pérez Navarro, Elisabet ^a   Rivero Juárez, Antonio ^b   Monje, Patricia ^c   Rivero, Antonio ^b   Macías, Juan ^c   Real, Luis Miguel ^c  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c NONE

Author keywords

Acute hepatitis; Epidemiology; Hepatitis E virus; HIV; Liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G;

ACUTE HEPATITIS; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DISEASE COURSE; EXPOSURE; FEMALE; FOLLOW UP; HEPATITIS E; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRANSAMINASEMIA; INCIDENCE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SPAIN; BLOOD; COINFECTION; COMPLICATION; HEPATITIS E VIRUS; IMMUNOLOGY; MIDDLE AGED; PREVALENCE;

ADULT; COHORT STUDIES; COINFECTION; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RNA, VIRAL; SPAIN;

EID: 84906795118     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000378     Document Type: Article

References (24)

1. Crum-Cianflone NF, Curry J, Drobeniuc J, Weintrob A, Landrum M, Ganesan A, et al. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis 2012; 18:502-506.
2. Sellier P, Mazeron MZ, Tesse S, Badsi E, Evans J, Magnier JD, et al. Virus infection in HIV infected patients with elevated serum transaminases levels. Virol J 2011; 8:171.
3. Jagjit Singh GK, Ijaz S, Rockwood N, Farnworth SP, Devitt E, Atkins M, et al. Chronic hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect 2013; 66:103-106.
4. Neukam K, Barreiro P, Macías J, Avellón A, Cifuentes C, Martín-Carbonero L, et al. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis 2013; 57:465-468.
5. Ramezani A, Velayati AA, Khorami-Sarvestani S, Eslamifar A, Mohraz M, Banifazl M, et al. Hepatitis E virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran. Int J STD AIDS 2013; 24:769-774.
6. Feldt T, Sarfo FS, Zoufaly A, Phillips RO, Burchard G, van Lunzen J, et al. Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon. J Clin Virol 2013; 58:18-23.
7. Mateos-Lindemann ML, Diez-Aguilar M, Galdamez AL, Galán JC, Moreno A, Pérez-Gracia MT. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol 2014; 86:71-74.
8. Maylin S, Stephan R, Molina JM, Peraldi MN, Scieux C, Nicand E, et al. Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised. J Clin Virol 2012; 53:346-349.
9. Kenfak-Foguena A, Schoni-Affolter F, Burgisser P, Witteck A, Darling KE, Kovari H, et al. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011; 17:1074-1078.
10. Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J, et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med 2012; 13:83-88.
11. Jardi R, Crespo M, Homs M, Van den Eyden E, Girones R, Rodríguez Manzano J, et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med 2012; 13:379-383.
12. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012; 367:1237-1244.
13. Kondili LA, Chionne P, Porcaro A, Madonna E, Taffon S, Resuli B, et al. Seroprevalence of hepatitis E virus (HEV) antibody and the possible association with chronic liver disease: a casecontrol study in Albania. Epidemiol Infect 2006; 134:95-101.
14. Kumar S, Subhadra S, Singh B, Panda BK. Hepatitis E virus: the current scenario. Int J Infect Dis 2013; 17:e228-e233.
15. Atiq M, Shire NJ, Barrett A, Rouster SD, Sherman KE, Shata MT. Hepatitis E virus antibodies in patients with chronic liver disease. Emerg Infect Dis 2009; 15:479-481.
16. Myint KS, Endy TP, Shrestha MP, Shrestha SK, Vaughn DW, Innis BL, et al. Hepatitis E antibody kinetics in Nepalese patients. Trans R Soc Trop Med Hyg 2006; 100:938-941.
17. Rivero-Juárez A, Martinez-Duenãs L, Martinez-Peinado A, Camacho A, Cifuentes C, Gordon A, et al. Chronic hepatitis E virus infection is uncommon in HIV-infected patients. Conference on Retroviruses and Opportunistic Infections, March 3-6 2014. Boston, United States of America (Abstract 633).
18. Kamar N, Bendall R, Legrand-Abravanel F, Xia N, Ijaz S, Izopet J, et al. Hepatitis E. Lancet 2012; 379:2477-2488.
19. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013; 207:497-500.
20. Pas SD, Streefkerk RH, Pronk M, de Man RA, Beersma MF, Osterhaus AD, van der Eijk AA. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 2013; 58:629-634.
21. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82:799-805.
22. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedougé M, Peron JM, Alric L, et al. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 2013; 58:624-628.
23. Rivero-Juarez A, Camacho A, Merchante N, Pérez-Camacho I, Macias J, Ortiz-García C, et al. Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/ HBV. PLoS One 2013; 8:e68953.
24. Merchante N, Pérez Camacho I, Mira JA, Rivero A, Macías J, Camacho A, et al. Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine. Antivir Ther 2010; 15:753-763.